Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics.

about

Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics.

Item

http://www.wikidata.org/entity/Q47721065

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics.

@en

Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics.

@nl

type

Item

label

Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics.

@en

Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics.

@nl

altLabel

Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics

@en

prefLabel

Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics.

@en

Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics.

@nl

P1476

Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics

@en

P2093

Ashok K Chopra

http://www.w3.org/2001/XMLSchema#string

Emily Reyes

http://www.w3.org/2001/XMLSchema#string

Eric C Fitts

http://www.w3.org/2001/XMLSchema#string

Jian Sha

http://www.w3.org/2001/XMLSchema#string

Jourdan A Andersson

http://www.w3.org/2001/XMLSchema#string

Michelle L Kirtley

http://www.w3.org/2001/XMLSchema#string

P2860

Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods

Early host cell targets of Yersinia pestis during primary pneumonic plague

Interleukin 12 a key immunoregulatory cytokine in infection applications

Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor

Yersinia pestis--etiologic agent of plague

Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options

Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.

Old drug new use--amoxapine and its metabolites as potent bacterial β-glucuronidase inhibitors for alleviating cancer drug toxicity.

Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Host-directed antimicrobial drugs with broad-spectrum efficacy against intracellular bacterial pathogens.

P31

scholarly article

P356

10.1128/AAC.01943-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sara M Dann

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29109161

http://www.w3.org/2001/XMLSchema#string

P921

Klebsiella pneumoniae

pneumonic plague

Clostridium difficile

Acinetobacter baumannii

Mouse Models

multiple drug resistance

P932

5740341

http://www.w3.org/2001/XMLSchema#string